Market Overview:
The global human serum albumin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for therapeutic use of albumin, and technological advancements in the field of recombinant albumin production. Based on type, the global human serum albumin market is segmented into recombinant and plasma-derived. The recombinant segment is expected to grow at a higher CAGR than the plasma-derived segment during the forecast period from 2018 to 2030. This can be attributed to technological advancements in recombinant protein production that have resulted in increased supply of high-quality recombinant proteins globally. Based on application, the global human serum albumin market is divided into hypoalbuminemia, hyperalbuminemia, therapeutic use, and other applications. The therapeutic use segment accounts for majority share of this market and is expected to grow at a higher CAGR than other segments during the forecast period from 2018 to 2030 owingto increasing demand for Albumin as a therapeutics across globe .
Product Definition:
Human serum albumin is a protein found in human blood. It is the most abundant protein in human blood and it helps to transport other nutrients and medications throughout the body. Albumin also plays a role in maintaining fluid balance within the body.
Recombinant:
Recombinant human serum albumin is a protein that is produced by the genetic engineering process. It has similar properties to that of human serum albumin and acts as a replacement for it in various applications such as therapeutic drug administration.
Plasma-derived:
Plasma-derived and its usage in Human Serum Albumin market is a new technology which helps to overcome the limitations of traditional separation techniques. It enables the production of highly pure human serum albumin with an ultra-low level of contaminants. The process involves plasma extraction from blood, which contains more than 90% protein along with other components such as immunoglobulins, coagulation factors, interferons etc., using a proprietary technique developed by Thermo Fisher Scientific.
Application Insights:
Hypoalbuminemia held the largest share of the overall revenue in 2017. According to data published by CDC, in 2016, about 1 in every 5 children under 5 years of age have been diagnosed with IDD. Moreover, according to estimates published by WHO in 2018, about 663 million people were affected by IDD worldwide. These factors are anticipated to boost demand for human serum albumin during the forecast period.
Therapeutic use segment is expected register fastest CAGR from 2018 to 2030 owingto increasing number of clinical trials using human serum albumin as a drug carrier for various diseases such as cancer and AIDS.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of product manufacturers and suppliers has fueled the growth of this region. Moreover, increasing R&D activities for the development of novel products is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising healthcare expenditure levels in emerging economies such as China and India. In addition, growing awareness about blood disorders among people is driving demand for human serum albumin in this region. Increasing incidence rate of cardiovascular diseases coupled with high mortality rate caused by infectious diseases are some other factors contributing toward regional market growth during the same period (2017-2030).
Growth Factors:
- Increasing demand for human serum albumin as a therapeutic agent in various diseases and disorders is expected to drive the market growth.
- Rising prevalence of chronic diseases such as cancer, diabetes, and respiratory disorders is also anticipated to fuel the demand for human serum albumin over the forecast period.
- Growing awareness about benefits of human serum albumin therapy is projected to propel the market growth in near future.
- Technological advancements in production process of human serum albumin are likely to provide new opportunities for market players over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Serum Albumin Market Research Report
By Type
Recombinant, Plasma-derived
By Application
Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other
By Companies
Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Human Serum Albumin Market Report Segments:
The global Human Serum Albumin market is segmented on the basis of:
Types
Recombinant, Plasma-derived
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
Highlights of The Human Serum Albumin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Recombinant
- Plasma-derived
- By Application:
- Hypoalbuminemia
- Hyperalbuminemia
- Therapeutic Use
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Serum Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human serum albumin is a protein that is found in the blood and other body fluids. It helps to keep the blood fluid and healthy.
Some of the key players operating in the human serum albumin market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang.
The human serum albumin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Serum Albumin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Serum Albumin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Serum Albumin Market - Supply Chain
4.5. Global Human Serum Albumin Market Forecast
4.5.1. Human Serum Albumin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Serum Albumin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Serum Albumin Market Absolute $ Opportunity
5. Global Human Serum Albumin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Serum Albumin Market Size and Volume Forecast by Type
5.3.1. Recombinant
5.3.2. Plasma-derived
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Serum Albumin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Serum Albumin Market Size and Volume Forecast by Application
6.3.1. Hypoalbuminemia
6.3.2. Hyperalbuminemia
6.3.3. Therapeutic Use
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Serum Albumin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Serum Albumin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Serum Albumin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Serum Albumin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Serum Albumin Demand Share Forecast, 2019-2026
9. North America Human Serum Albumin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Serum Albumin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Serum Albumin Market Size and Volume Forecast by Application
9.4.1. Hypoalbuminemia
9.4.2. Hyperalbuminemia
9.4.3. Therapeutic Use
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Serum Albumin Market Size and Volume Forecast by Type
9.7.1. Recombinant
9.7.2. Plasma-derived
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Serum Albumin Demand Share Forecast, 2019-2026
10. Latin America Human Serum Albumin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Serum Albumin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Serum Albumin Market Size and Volume Forecast by Application
10.4.1. Hypoalbuminemia
10.4.2. Hyperalbuminemia
10.4.3. Therapeutic Use
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Serum Albumin Market Size and Volume Forecast by Type
10.7.1. Recombinant
10.7.2. Plasma-derived
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Serum Albumin Demand Share Forecast, 2019-2026
11. Europe Human Serum Albumin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Serum Albumin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Serum Albumin Market Size and Volume Forecast by Application
11.4.1. Hypoalbuminemia
11.4.2. Hyperalbuminemia
11.4.3. Therapeutic Use
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Serum Albumin Market Size and Volume Forecast by Type
11.7.1. Recombinant
11.7.2. Plasma-derived
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y--Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Serum Albumin Demand Share, 2019-2026
12. Asia Pacific Human Serum Albumin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Application
12.4.1. Hypoalbuminemia
12.4.2. Hyperalbuminemia
12.4.3. Therapeutic Use
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Type
12.7.1. Recombinant
12.7.2. Plasma-derived
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Serum Albumin Demand Share, 2019-2026
13. Middle East & Africa Human Serum Albumin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Application
13.4.1. Hypoalbuminemia
13.4.2. Hyperalbuminemia
13.4.3. Therapeutic Use
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Type
13.7.1. Recombinant
13.7.2. Plasma-derived
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Serum Albumin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Serum Albumin Market: Market Share Analysis
14.2. Human Serum Albumin Distributors and Customers
14.3. Human Serum Albumin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Grifols
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CSL
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Octapharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biotest
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kedrion
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hualan Bio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CNBG
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai RAAS
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. CBPO
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. LFB Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BPL
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sichuan Yuanda Shuyang
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook